ArticleHemaSphere2026

Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single-cell profiling in anti-BCMA CAR T-treated myeloma.

Thomas C Wiemers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.